Martin & Co. Inc. TN Purchases Shares of 340,771 Viemed Healthcare, Inc. $VMD

Martin & Co. Inc. TN acquired a new position in Viemed Healthcare, Inc. (NASDAQ:VMD) in the second quarter, Holdings Channel.com reports. The institutional investor acquired 340,771 shares of the company’s stock, valued at approximately $3,885,000.

Several other institutional investors also recently modified their holdings of VMD. State of Alaska Department of Revenue bought a new stake in shares of Viemed Healthcare during the fourth quarter valued at approximately $25,000. Kemnay Advisory Services Inc. bought a new position in Viemed Healthcare in the fourth quarter worth $46,000. Quarry LP bought a new position in Viemed Healthcare in the third quarter worth $48,000. AQR Capital Management LLC acquired a new stake in Viemed Healthcare during the first quarter worth $90,000. Finally, R Squared Ltd acquired a new stake in Viemed Healthcare during the fourth quarter worth $102,000. Institutional investors and hedge funds own 74.24% of the company’s stock.

Insider Buying and Selling

In other Viemed Healthcare news, Director Timothy Smokoff sold 20,000 shares of the company’s stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $11.50, for a total transaction of $230,000.00. Following the transaction, the director owned 75,518 shares of the company’s stock, valued at approximately $868,457. This represents a 20.94% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider William Frazier sold 10,000 shares of the company’s stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $11.72, for a total transaction of $117,200.00. Following the transaction, the insider owned 73,214 shares in the company, valued at approximately $858,068.08. The trade was a 12.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 20.60% of the stock is currently owned by corporate insiders.

Viemed Healthcare Trading Up 3.3%

Shares of Viemed Healthcare stock opened at $8.85 on Friday. Viemed Healthcare, Inc. has a 12-month low of $6.05 and a 12-month high of $12.61. The stock has a market capitalization of $337.10 million, a P/E ratio of 24.58 and a beta of 1.10. The company has a 50-day simple moving average of $10.98 and a 200 day simple moving average of $9.86. The company has a quick ratio of 1.02, a current ratio of 1.13 and a debt-to-equity ratio of 0.04.

Viemed Healthcare (NASDAQ:VMD) last released its quarterly earnings results on Monday, August 3rd. The company reported $0.07 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.05). The firm had revenue of $78.10 million during the quarter, compared to analyst estimates of $78.00 million. Viemed Healthcare had a net margin of 4.81% and a return on equity of 10.16%. Research analysts expect that Viemed Healthcare, Inc. will post 0.42 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on VMD. Wall Street Zen cut shares of Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 15th. Weiss Ratings lowered shares of Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, August 17th. Finally, Freedom Capital cut shares of Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 5th. Three equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Viemed Healthcare currently has an average rating of “Hold”.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.